A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.
The Paper House expands into hybrid publishing, offering authors more flexible and professional publishing options.
A landmark global study co‑led by Dalhousie researchers offers the clearest picture yet of anxiety’s biological roots, ...
New Practice Group Targets Businesses That Benefit From Trafficking, Including Hotels and Motels These cases reflect a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results